Press Releases from WuXi AppTec (13 total)
Safeguarding Innovation: WuXi AppTec's Commitment to IP Protection
The pharmaceutical industry faces immense innovation investments and lengthy cycles. Developing and launching a new drug can take 10-15 years and cost billions of dollars.…
WuXi AppTec's Presence to Europe: Building Sustainable Growth Through Local Empo …
Europe has become a dynamic center for biopharmaceutical development, where cutting-edge science is increasingly expected to align with sustainability and community responsibility. In this evolving…
Unpacking the Business Logic: A Deep Dive into WuXi AppTec's Value Proposition
The pharmaceutical industry is at a crossroads, where traditional drug development models are being challenged by economic pressures and scientific complexities. As R&D costs continue…
Building Sustainable Growth: How WuXi AppTec Empowers Local Ecosystems in Europe
Europe has long been a hub for scientific excellence, yet the region continues to face challenges in translating groundbreaking discoveries into sustainable biotech ventures. While…
WuXi AppTec: Integrating in Local European Ecosystems for Sustainable Growth
In the dynamic landscape of global biopharma, collaboration and a commitment to sustainable development have become pivotal. Companies that not only deliver innovative solutions but…
WuXi AppTec's Global Footprint: Serving Partners Across Asia, Europe, and North …
In recent years, the pharmaceutical and life sciences industry has placed greater emphasis on collaboration across borders. Innovation increasingly depends on research and development organizations…
How WuXi AppTec's CRDMO Model Drives Business Growth
In an era where pharmaceutical innovation propels global healthcare progress, WuXi AppTec has established itself as a significant player in the Contract Research, Development, and…
Unlocking Europe's Pharma Potential: How WuXi AppTec Bridges the Innovation-to-M …
Europe's pharma sector is a hotbed of scientific innovation, but translating those discoveries into commercially viable drugs is no picnic. That's where WuXi AppTec (https://www.wuxiapptec.com/),…
WuXi AppTec Pioneering Role in Advancing Targeted Protein Degradation
Envision a drug that not only turns off toxic proteins but destroys them entirely, fighting disease that we previously thought couldn't be treated. That is…
How WuXi AppTec Embeds Quality: A Global Blueprint for Trust and Excellence
In the pharmaceutical and life sciences industries, quality is paramount. A lapse in drug development or manufacturing quality can have catastrophic consequences, directly impacting human…
Bridging Innovation and Commercial Success: The Strategic Value of Integrated CR …
The Innovation Paradox in Modern Drug Development
The biopharmaceutical industry faces a paradox: scientific breakthroughs emerge rapidly, but translating them into therapies is extremely challenging. Industry…
WuXi AppTec's Enduring Strength: The CRDMO Model as a Foundation for Long-Term G …
WuXi AppTec is a pivotal global enabler in the pharmaceutical and life sciences industries, committed to advancing healthcare innovation through its comprehensive R&D and manufacturing…
WuXi AppTec's New EU Batch Release Services: What This Means for European Biotec …
WuXi AppTec (https://www.wuxiapptec.com/) has achieved a key milestone for EU pharmaceutical market access: WuXi STA, its subsidiary, marks the official launch of EU batch release…
Go To Page:
